Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Editorial introductions

Editorial introductions Editorial introduction Current Opinion in HIV and AIDS was launched in 2006. It School of Medicine, he is currently the Director is one of a successful series of review journals whose of Clinical Research in Biodefense and Infectious unique format is designed to provide a systematic and Diseases. critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are Dr Murphy’s primary research interest is HIV infection. divided into 6 sections that are reviewed once a year. His research includes drug development of new antire- Each section is assigned a Section Editor, a leading troviral and anti-hepatitis agents, therapeutic vaccines, authority in the area, who identifies the most important treatment and management of the complications of anti- topics at that time. Here we are pleased to introduce one viral therapy, and the scaling up of antiretroviral therapy of the Journal’s Section Editors for this issue. and treatment programs in Africa. Section Editor Dr Murphy is the Principal Investigator for the National Institutes for Allergy and Infectious Diseases (NIAID) Robert Murphy Adult AIDS Clinical Trials Group (ACTG) at North- western. Within the ACTG he has held numerous leader- Dr Robert L. Murphy ship positions including chairing the Complications of received his AB from Boston HIV Disease Committee and being a member of the University, following which Scientific Agenda Steering Committee. He currently he attended the Loyola serves on the Adult Executive Committee, the governing Stritch School of Medicine body of the group. He is a member of multiple medical and later completed his societies and sits on the boards of several non-profit internship, residency and organizations including the Objectif Recherche Vaccin fellowship in infectious dis- SIDA, the International AIDS Education Project, the eases at the McGaw Medical Midwest AIDS Foundation, of which he is a co-founder, Center, Northwestern Uni- the Drucker Family Charitable Trust. International versity. Dr Murphy has activities and interests include assisting in the establish- remained with Northwes- ment of an AIDS Clinic on the Mbirikani Group Ranch in tern ever since, earning the the Maasai area of southern Kenya funded by the African title Professor of Medicine Infectious Disease Village Clinics Foundation; he in 1999. He currently holds the position of the John P. recently assisted in writing the rationale for the antire- Phair Professor of Infectious Diseases at Northwestern troviral treatment program with the Nigerian Institute for and Adjunct Professor of Immunology and Infectious Medical Research in Lagos, Nigeria, and he is the Nigeria Diseases at the Harvard School of Public Health. Country Director of Harvard’s President’s Emergency In addition to his roles as a university-based physician Program for AIDS Relief. He also consults on NIH- and and professor at Northwestern University’s Feinberg Gates Foundation-supported projects in Senegal. Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in HIV and Aids Wolters Kluwer Health

Editorial introductions

Current Opinion in HIV and Aids , Volume 1 (6) – Nov 1, 2006
Download PDF
1 page

Loading next page...
 
/lp/wolters-kluwer-health/editorial-introductions-lp4EVunZ80

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1746-630X
eISSN
1746-6318
DOI
10.1097/01.COH.0000250320.30067.b2
Publisher site
See Article on Publisher Site

Abstract

Editorial introduction Current Opinion in HIV and AIDS was launched in 2006. It School of Medicine, he is currently the Director is one of a successful series of review journals whose of Clinical Research in Biodefense and Infectious unique format is designed to provide a systematic and Diseases. critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are Dr Murphy’s primary research interest is HIV infection. divided into 6 sections that are reviewed once a year. His research includes drug development of new antire- Each section is assigned a Section Editor, a leading troviral and anti-hepatitis agents, therapeutic vaccines, authority in the area, who identifies the most important treatment and management of the complications of anti- topics at that time. Here we are pleased to introduce one viral therapy, and the scaling up of antiretroviral therapy of the Journal’s Section Editors for this issue. and treatment programs in Africa. Section Editor Dr Murphy is the Principal Investigator for the National Institutes for Allergy and Infectious Diseases (NIAID) Robert Murphy Adult AIDS Clinical Trials Group (ACTG) at North- western. Within the ACTG he has held numerous leader- Dr Robert L. Murphy ship positions including chairing the Complications of received his AB from Boston HIV Disease Committee and being a member of the University, following which Scientific Agenda Steering Committee. He currently he attended the Loyola serves on the Adult Executive Committee, the governing Stritch School of Medicine body of the group. He is a member of multiple medical and later completed his societies and sits on the boards of several non-profit internship, residency and organizations including the Objectif Recherche Vaccin fellowship in infectious dis- SIDA, the International AIDS Education Project, the eases at the McGaw Medical Midwest AIDS Foundation, of which he is a co-founder, Center, Northwestern Uni- the Drucker Family Charitable Trust. International versity. Dr Murphy has activities and interests include assisting in the establish- remained with Northwes- ment of an AIDS Clinic on the Mbirikani Group Ranch in tern ever since, earning the the Maasai area of southern Kenya funded by the African title Professor of Medicine Infectious Disease Village Clinics Foundation; he in 1999. He currently holds the position of the John P. recently assisted in writing the rationale for the antire- Phair Professor of Infectious Diseases at Northwestern troviral treatment program with the Nigerian Institute for and Adjunct Professor of Immunology and Infectious Medical Research in Lagos, Nigeria, and he is the Nigeria Diseases at the Harvard School of Public Health. Country Director of Harvard’s President’s Emergency In addition to his roles as a university-based physician Program for AIDS Relief. He also consults on NIH- and and professor at Northwestern University’s Feinberg Gates Foundation-supported projects in Senegal. Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.

Journal

Current Opinion in HIV and Aids – Wolters Kluwer Health

Published: Nov 1, 2006

There are no references for this article.